Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial

por Belliveau, C., Barkati, M., Delouya, G., Taussky, D., Beauchemin, M. C., Lambert, C., Beaulieu, L., Beliveau-Nadeau, D., Nicolas, B., Carrier, J. F., Vigneault, E., Ménard, C.
Publicado 2022